Chitin Scaffolds in Tissue Engineering by Jayakumar, Rangasamy et al.
Int. J. Mol. Sci. 2011, 12, 1876-1887; doi:10.3390/ijms12031876 
 
International Journal of 
Molecular Sciences 
ISSN 1422-0067 
www.mdpi.com/journal/ijms 
Review 
Chitin Scaffolds in Tissue Engineering 
Rangasamy Jayakumar 
1,*, Krishna Prasad Chennazhi 
1, Sowmya Srinivasan 
1,  
Shantikumar V. Nair 
1, Tetsuya Furuike 
2 and Hiroshi Tamura 
2,*
 
1  Amrita Center for Nanosciences and Molecular Medicine, Amrita Institute of Medical Sciences and 
Research Centre, Cochin-682041, India; E-Mails: drkrishnaprasadc@aims.amrita.edu (K.P.C.); 
sowmyasrinivasan@aims.amrita.edu (S.S.); shantinair@aims.amrita.edu (S.V.N.) 
2  Faculty of Chemistry, Materials and Bioengineering, Kansai University, Osaka-564-8680, Japan;  
E-Mail: furuike@kansai-u.ac.jp (T.F.) 
*  Authors to whom correspondence should be addressed; E-Mails: rjayakumar@aims.amrita.edu (R.J.); 
tamura@kansai-u.ac.jp (H.T.); Tel.: +91-484-2801234; Fax: +91-484-2802020. 
Received: 15 December 2010; in revised form: 18 February 2011 / Accepted: 11 March 2011 /  
Published: 15 March 2011 
 
Abstract:  Tissue  engineering/regeneration  is  based  on  the  hypothesis  that  healthy 
stem/progenitor  cells  either  recruited  or  delivered  to  an  injured  site,  can  eventually 
regenerate lost or damaged tissue. Most of the researchers working in tissue engineering 
and regenerative technology attempt to create tissue replacements by culturing cells onto 
synthetic porous three-dimensional polymeric scaffolds, which is currently regarded as an 
ideal  approach  to  enhance  functional  tissue  regeneration  by  creating  and  maintaining 
channels  that  facilitate  progenitor  cell  migration,  proliferation  and  differentiation.  The 
requirements that must be satisfied by such scaffolds include providing a space with the 
proper  size,  shape  and  porosity  for  tissue  development  and  permitting  cells  from  the 
surrounding tissue to migrate into the matrix. Recently, chitin scaffolds have been widely 
used in tissue engineering due to their non-toxic, biodegradable and biocompatible nature. 
The advantage of chitin as a tissue engineering biomaterial lies in that it can be easily 
processed into gel and scaffold forms for a variety of biomedical applications. Moreover, 
chitin  has  been  shown  to  enhance  some  biological  activities  such  as  immunological, 
antibacterial, drug delivery and have been shown to promote better healing at a faster rate 
and exhibit greater compatibility with humans. This review provides an overview of the 
current status of tissue engineering/regenerative medicine research using chitin scaffolds 
for bone, cartilage and wound healing applications. We also outline the key challenges in 
this  field  and  the  most  likely directions  for future development  and we hope that this 
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review will be helpful to the researchers working in the field of tissue engineering and 
regenerative medicine. 
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1. Introduction  
Chitin,  extracted  primarily  from  shellfish  sources,  is  a  unique  biopolymer  based  on  the  
N-acetyl-glucosamine monomer. It is a co-polymer of N-acetyl-glucosamine and N-glucosamine units 
randomly or block distributed throughout the biopolymer chain depending on the processing method 
used to derive the biopolymer. When the number of N-acetyl-glucosamine units is higher than 50%, 
the biopolymer is termed chitin. Chitin, together with its derivatives, has been shown to be useful as a 
wound dressing material, drug delivery vehicle and an essential candidate for tissue engineering. The 
promise for this biomaterial is vast and will grow as and when the chemistry extends its capabilities 
with  further  investigations  of  new  biomedical  applications.  The  present  generation  of  tissue 
engineering/regenerative medicine research seeks to reinstate the function of injured tissues through 
the seeding of cells onto porous biodegradable polymer matrixes. In most of the cases, including the 
bone and cartilage systems, function relies on transmission or generation of mechanical forces and 
maintenance of blood circulation. Tissues such as articular cartilage have specialized structure and 
composition which help to provide mechanical and transport properties. As of now, there are only a 
few engineered tissue products available for clinical use. Most of the implants fail because of the 
transport limitations leading to death of the implanted cells. The extent of mechanical stresses that 
tissues may be subjected to, under in vivo conditions can be quite large and there are hardly any 
engineered tissue constructs  which possess the properties to withstand such trauma at the time of 
implantation. Moreover, the challenge is not limited to match a single mechanical parameter, such as 
elastic modulus or strength; rather, most tissues have intricate viscoelastic, nonlinear and anisotropic 
mechanical properties that may vary with age, site of implantation and a multitude of other factors. A 
primary limiting factor in tissue engineering research is the availability of suitable biomaterials to 
serve as the temporary matrix. These biomaterials must be capable of being prepared in various shapes 
and sizes with sufficient porosity to offer a channel for the migration of host cells into the matrix, thus 
permitting growth into complete tissue analogs and be biodegradable generating non-toxic products 
once they have served their function in vivo.  
Chitin  is  a  biodegradable  polymer  and  it  can  be  easily  processed  into  membranes  [1–8],  
nanofibers [9,10], gels [11–13] and scaffold [14–16] forms. Chitin scaffolds and membranes have been 
reported to be suitable for bone [17–21] and wound [22–25] tissue engineering applications. This 
review presents an overview of the more recent research area of orthopedic, bone and wound tissue 
engineering applications of chitin scaffolds. Int. J. Mol. Sci. 2011, 12                       
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2. Chitin Scaffolds in Tissue Engineering 
Tissue  engineering  is  a  multidisciplinary  science,  encompassing  diverse  fields  like  materials 
engineering and molecular biology with efforts to develop biological substitutes for failing tissues and 
organs.  Tissue  engineering  thus  seeks  to  replace  diseased  and  damaged  tissues  of  the  body.  For 
successful tissue regeneration, it is absolutely indispensable not only to have cells of high proliferation 
and differentiation potential, but also to create an environment suitable for inducing regeneration. Such 
creation can be artificially achieved only by providing various biomaterials to promote cell proliferation 
and differentiation along with proper cells and growth factors. A number of biodegradable polymers 
have  been  explored  for  tissue  engineering  purposes.  These  include  synthetic  polymers  like 
poly(caprolactone),  poly(lactic-co-glycolic  acid),  poly(ethylene  glycol),  poly(vinyl  alcohol)  and 
natural polymers like alginate, collagen, gelatin, chitin and chitosan etc. [26,27]. Of these, chitin and 
its derivatives have shown tremendous promise as tissue supporting materials. 
2.1. Bone 
Growth of functional  tissues include regeneration of specific cells  in  tissues  by facilitating the 
differentiation of stem cells, or the attachment and proliferation of particular cell types in judiciously 
designed  nanomaterial-based  assemblies.  Regeneration  is  based  on  the  hypothesis  that  healthy 
progenitor  cells  either  recruited  or  delivered  to  an  injured  site,  can  eventually  regenerate  lost  or 
damaged bone tissue. Tissue engineering approaches attempt to create tissue replacements by culturing 
cells onto synthetic three-dimensional polymer matrixes [28]. Three-dimensional porous polymeric 
matrixes are seen as one approach to enhance bone regeneration by creating and maintaining channels 
that facilitate progenitor cell migration, proliferation, and differentiation [29]. The requirements that 
must be satisfied by such matrixes include providing a space with the proper size and shape for tissue 
development and permitting cells from the surrounding tissue to migrate into the matrix [30]. The 
surface  of  the  polymer  would  also  ideally  promote  cell  attachment,  as  many  cells  are  anchorage 
dependent for their survival. 
The polymer with a mineral to provide a “composite” material that has the toughness and flexibility 
of  the  polymer  with  the  strength  and  hardness  of  the  mineral  filler  has  its  beginnings  in  nature. 
Recently, “composites” based on polymer matrix-calcium-based compounds systems are of potential 
use as hard tissue substitute materials. The advantage of such “composites” was believed to be the 
enhancement of the osteogenic potential due to the presence of calcium compounds and the binder 
characteristics of the polymer matrix in inhibiting migration of the calcium compounds. For example, 
the combination of polymer with hydroxyapatite (HA) has been shown to maximize the osteo-conductive 
behavior of HA in vivo, allowing bony in-growths to occur into the implant as the matrix progressively 
resorbs [31,32]. Therefore, HA or other calcium containing materials incorporated into chitin have 
been the primary research area where orthopedic or bone substitution and periodontal applications 
were the  focus.  In a series  of studies,  Wan  et  al. have investigated the interaction of chitin  with 
calcium species. In one strategy, Wan et al. combined chitin with HA to produce a new HA-chitin 
“composite”  material  by  dispersing  HA  into  chitin  to  give  an  intimately  blended  material  [33]. 
Preliminary  mechanical  test  results  revealed  a  reduction  in  strength  for  the  more  highly  filled Int. J. Mol. Sci. 2011, 12                       
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composites,  but  they  also  revealed  retention  of  the  plastic  properties  of  the  polymer  that  may  be 
favorable  for  bone  replacement  applications.  Wan  et  al.  also  investigated  the  induction  of  in  situ 
calcification  by  chitin.  It  was  theorized  that  if  chitin  was  chemically  modified  with  anionic 
carboxymethyl (CM) groups, a chitin matrix with surface acidic CM residues becoming a calcium ion 
attractor site, could be prepared [34]. If the chitin matrix is placed in the presence of calcium and 
phosphate ions, the CM chitin would draw calcium ions to it. The calcium ions in turn would pull 
phosphate ions, forming the basis of calcium phosphate nucleation that eventually would give rise to 
calcium apatite on the chitin platform. The results of this preliminary work indicated that higher the 
CM content, the better the calcification, suggesting a role for in vivo calcification promotion by chitin. 
Subsequently, the nucleation idea was refined by preparing the chitin in the form of porous chitin 
matrixes obtained by freeze-drying chitin gels followed by chemically modifying their surfaces with 
CM  and  phosphoryl  (P-chitin)  ionic  groups  [35,36].  The  more  porous  nature  of  this  method  of 
preparation of the chitin matrix was thought to provide more opportunity for “through matrix” calcium 
ions attraction that would lead to more substantial calcium phosphate-chitin material. The results from 
these studies indicated that a calcium phosphate phase could be efficiently grown onto a pre-formed 
chitin  template  by  incubating  in  a  metastable  solution  supersaturated  with  respect  to  calcium 
phosphate. High levels of calcium phosphate (54.6% of final composite mass) were incorporated into 
the porous chitin matrix (Ca_P = 8 mm
2). An average of 19.5% by mass of calcium phosphate (as 
percentage of final composite mass) was deposited on the CM chitin, under the same conditions. In 
this study the P-chitin was found to have an inhibitory effect on calcium ion recruitment. 
One of the most attempted methods to prepare chitin for cell seeding is to first make a precursor that 
is typically a gel followed by various lyophilization strategies. A series of porous chitin matrixes were 
obtained  by  producing  chitin  gels  from  chitin  solutions  further  lyophilized  to  give  porous  chitin 
matrixes [35–37]. Matrix pore sizes ranging from 100 to 500 mm were obtainable depending on the 
various  pre-treatment  procedures  of  chitin  gels  prior  to  lyophilization  [37].  Mouse  and  human 
fibroblast  cell  cultures  exposed  to  these  chitin  matrixes  were  found  to  grow  and  proliferate  well 
indicating the feasibility of using these porous chitin matrixes for cell transplantation applications to 
regenerate tissues. Similarly, Wang et al. have demonstrated the preparation of chitin-plasma sprayed 
calcium HA matrixes [38]. HA in 25, 50 and 75% w/w fractions was incorporated into chitin solutions 
and air and freeze-dried to develop porous like scaffold [39]. These HA-chitin porous scaffolds were 
exposed to cell cultures and implanted into the intramusculature of a rat model. The HA-chitin scaffold 
were  found  to  be  non-cytotoxic  and  degraded  in  vivo.  The  presence  of  the  HA  filler  enhanced 
calcification as well as accelerated degradation of the chitin matrix. The prepared HA-chitin matrixes 
were selected for further cell seeding experiments. Mesenchymal stem cells harvested from NZW 
rabbits differentiated into osteoblasts in vitro using dexamethasone. These osteoblasts were cultured 
for one week, statically loaded onto the porous HA-chitin matrixes and implanted into bone defects of 
the rabbit femur for two months. Histology of explants showed bone regeneration with biodegradation 
of  the  HA-chitin  matrix.  Similarly,  green  fluorescence  protein  (GFP)  transfected  MSC-induced 
osteoblasts were also loaded onto porous HA-chitin matrixes and implanted into the rabbit femur. The 
results  from  GFP-transfected  MSCs  showed  that  loaded  MSCs-induced  osteoblasts  did  not  only 
proliferate but also recruited the ingrowth of surrounding tissue. These results indicated that HA-chitin 
matrixes could be good candidates for tissue engineered bone substitute [39]. Int. J. Mol. Sci. 2011, 12                       
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A CMC/HA composite was prepared and examined for their effects on bone repair in cell lines and 
in animals [40]. The efficiency of bone formation by CMC/HA composite was compared with CMC, 
HA  or  blank  by  implantation  of  those  materials  in  animals  in  vivo.  The  new  bone  formation  of 
CMC/HA composite was superior to that of CMC, HA or blank. Thus, a porous CMC/HA composite 
could act as a scaffold for osteoblast-like cells and a barrier to in growth of fibrous connective tissues. 
The cytotoxicity of CMC was evaluated using the MC3T 3-E1 cell line. Cells had very low toxicity 
when the DD of CMC was 0.1%. It is evident that the control of DD is a very important factor in using 
CMC as a bone repair material. The CMC/HA composite showed high blood absorbing property and 
was tightly fixed in the bone defect without flowing out during periosteum suturing, while HA was 
easy to flow out of the bone defect by bleeding from the bone marrow cavity [40]. β-chitin hydrogel 
scaffolds were also developed by lyophilization technique [14]. The bioactivity studies of  β-chitin 
scaffolds studied using SBF solution showed that there is a calcium phosphate layer on the surface as 
well as in the cross section of β-chitin scaffolds. It appears that β-chitin scaffolds can also be used for 
bone tissue engineering [14]. 
nHA  with  the  chemical  formula  Ca10(PO4)6(OH)2  is  commonly  used  for  various  biomedical 
applications owing to its unique functional properties of high surface area to volume ratio and it also 
mimics  the  apatite  like  structure  and  composition  of  hard  tissues  such  as  enamel,  dentin  and  
bone [39,41]. It is stable in body fluids, bioactive, osteoconductive, non-toxic, non inflammatory, non 
immunogenic and does not decompose [42,43]. It has the ability to form a direct chemical bond with 
the  surrounding  hard  tissues  [44].  In  addition  it  offers  other  advantages  such  as  easy  fabrication, 
handling  and  close  surface  contact  with  the  surrounding  tissues  [45].  β-chitin/HA  nanocomposite 
scaffolds  were  synthesized  from  a  mixture  of  β-chitin  hydrogel  and  nHA  by  freeze-drying 
technique [46]. The cytocompatibility of the nanocomposite scaffolds was studied using MG 63 cells. 
The results indicated that the cells were viable and showed enhanced attachment and proliferation onto 
the nanocomposite scaffolds. Similar results were observed with α-chitin/HA nanocomposite scaffolds 
synthesized from α-chitin hydrogel and nHA by freeze-drying approach [47]. These results essentially 
signify that the synthesized nanocomposite scaffolds can serve as potential candidates for bone tissue  
engineering [46,47]. 
Bioactive glass ceramics are silicate-based materials used for bone repair and are widely used in 
orthopedics and dentistry [48,49]. They can also bond to both soft and hard tissue and are superior to 
HA  in  their  ability  for  osseointegration  and  osteoblast  and  marrow  stromal  cell  proliferation  and 
differentiation  [50–56].  In  addition,  the  bioactive  glass  ceramics  influence  osteoblastic  cell 
differentiation  with  an  increase  in  the  level  of  differentiation  markers  like  ALP,  osteocalcin  and 
osteopontin  [55,56].  Bioactive  glass  ceramic  nanoparticles  (nBGC)  were  prepared  using  sol-gel 
technique  [16].  The  α-chitin/nBGC  and  β-chitin/nBGC  composite  scaffolds  were  prepared  using  
α-chitin/β-chitin hydrogel with nBGC by lyophilization technique [16,17]. The biocompatibility of the 
composite scaffolds was studied using MTT assay and cell attachment studies on MG63 and POB 
cells. Results indicated no signs of toxicity and the MG63 and POB cells were well adhered onto the 
scaffolds. These results suggested that the developed composite scaffolds have promising applications 
in alveolar bone tissue engineering [16,17].  
Addition of silica nanoparticles enhances the bioactivity and biocompatibility of chitin. Recently,  
α-chitin  composite  scaffold  containing  nanosilica  was  developed  using  α-chitin  hydrogel  [15]. Int. J. Mol. Sci. 2011, 12                       
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Bioactivity, swelling ability and cytotoxicity of α-chitin composite scaffolds were analyzed in vitro. 
These  scaffolds  were  found  to  be  bioactive  in  SBF  and  biocompatible  with  MG63  cell  line. The  
α-chitin/nanosilica  composite  scaffolds  showed  higher  biocompatibility.  These  results  suggest  that  
α-chitin/nanosilica composite scaffolds can be useful for bone tissue engineering [15]. 
Polymeric nanofibrous scaffolds can mimic the structure and function of the natural extracellular 
matrix (ECM). These materials are of great interest in tissue engineering as scaffolding materials to 
restore, maintain or improve the function of human tissues. The natural ECMs in the body are mainly 
composed of two classes of extracellular macromolecules: proteoglycans and fibrous proteins with 
fiber diameter ranging from 50 to 150 nm, depending on the tissue type [57]. Recent studies showed 
that the material size feature could substantially influence the morphology and function of cells grown 
on  the  ECM.  The  attachment  and  proliferation  of  cells  were  found  to  be  good  on  micro  and 
nanostructured  materials  [58,59].  Collagen  is  a  major  natural  extracellular  matrix  component  and 
possesses a fibrous structure with fiber bundles varying in diameter from 50 to 500 nm [58,60]. Much 
effort  has  been  made  to  find  an  alternative  scaffold  material  with  similar  physicochemical  and 
biological characteristics of ECM [61]. The morphology of electrospun nanofiber mat is very similar to 
the morphology  of  human native  ECM [62–64]  thus; electrospun nanofiber could  be a promising 
scaffolding material for cell culture and tissue engineering application. The electrospinning process 
makes it possible to produce complex, seamless and three-dimensional (3D) nanofibrous scaffolds that 
support diverse types of cells to form artificial tissues. 
Electrospun water-soluble carboxymethyl chitin (CMC)/PVA blend nanofibrous scaffold for tissue 
engineering applications has been reported [10]. The prepared nanofibers were found to be bioactive 
and biocompatible. Cytotoxicity and cell attachment studies of the nanofibrous scaffold were evaluated 
using human mesenchymal stem cells (hMSCs) by the MTT assay. Cell attachment studies revealed 
that cells were able to attach and spread throughout the nanofibrous scaffolds. These results indicated 
that the nanofibrous CMC/PVA scaffold support cell adhesion/attachment and proliferation and hence 
this scaffold can be a useful candidate for bone tissue engineering [10]. 
2.2. Cartilage 
Articular cartilages have distinctive mechanical properties to withstand the demands of repetitive 
loading. However, this tissue exhibits little or no wear, even with recurring loading cycles that may 
even exceed 8–12 times the body weight of the individual. This inimitable property of the cartilage 
tissue has been attributed to its complex structure and unique extra cellular matrix composition, which 
provides mechanical properties that are anisotropic, nonlinear, inhomogeneous and viscoelastic [65]. 
Additionally,  the  fixed  negative  charge  maintained  in  the  extra  cellular  matrix  due  to  the  high 
concentration of aggrecan and other proteoglycans increases the internal swelling pressures providing 
inhomogeneous residual stresses within normal articular cartilage.  
Chitin  has  the  ability  to  maintain  the  morphology  of  chondrocytes,  a  normal  phenotypic 
characteristic  and  preserve  their  capacity  to  synthesize  cell-specific  extracellular  matrix.  Scaffolds 
made from pure β-chitin showed the efficiency in supporting chondrocytes (ca. 98%) and the same 
concentration  of  chondroitin  sulfate  [66].  The  content  of  hydroxyproline  in  the  β-chitin  sponge 
scaffold  was  significantly  greater  than  in  other  sponges  at  week  4,  post-culture.  From  the Int. J. Mol. Sci. 2011, 12                       
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histochemical and immuno-histochemical findings, the cartilage-like layer in the chondrocytes-sponge 
composites was similar to hyaline cartilage. However, only in the pure β-chitin sponge scaffold, type II 
collagen was closer to that of normal rabbit cartilage [66]. These results indicated that pure β-chitin 
sponge scaffold can be used for cartilage tissue engineering.  
2.3. Wound 
Chitin has an accelerating effect on the wound healing process. The main biochemical activities of 
chitin based materials in wound healing are polymorphonuclear cell activation, fibroblast activation, 
cytokine  production,  giant  cell  migration  and  simulation  of  type  IV  collagen  synthesis  [67].  
The  cytocompatibility  of  chitin  nanofibrous  scaffold  was  studied  for  wound  tissue  engineering  
applications [68]. Chitin nanofibous scaffolds were found to promote cell attachment and spreading of 
normal  human  keratinocytes  and  fibroblasts  compared  to  chitin  microfibers.  This  may  be  a 
consequence  of  the  high  surface  area  available  for  cell  attachment  due  to  their  three-dimensional 
features and high surface area to volume ratios, which are favorable parameters for cell attachment, 
growth  and  proliferation.  Cell  studies  conducted  on  chitin/PGA  [69]  and  chitin/SF  [70]  fibrous 
scaffolds proved that a matrix consisting of 25% PGA or SF and 75% chitin had the best results. The 
chitin/PGA  fibrous  scaffold  had  a  bovine  serum  albumin  coating  and  was  considered  as  a  good 
candidate  for  use  as  a  tissue  engineering  scaffold.  The  chitin/SF  fibrous  scaffold  had  the  highest 
spreading of normal human epidermal fibroblasts (NHEF) and normal human epidermal keratinocytes 
(NHEK). Therefore, these scaffolds were recommended for wound tissue engineering applications. 
β-chitin/HA nanocomposite scaffolds were synthesized from a mixture of β-chitin hydrogel and 
nHA  by  freeze-drying  technique  [46].  The  cytocompatibility  of  the  nanocomposite  scaffolds  was 
studied  using  Vero,  NIH  3T3  and  HDF  cells.  The  results  indicated  non-toxicity  with  enhanced 
attachment and proliferation of these cells  onto the nanocomposite scaffolds.  Similar results  were 
observed with α-chitin/HA nanocomposite scaffolds synthesized from α-chitin hydrogel and nHA by 
freeze-drying  approach  [47].  These  results  essentially  signify  that  the  synthesized  nanocomposite 
scaffolds can serve as potential candidates for wound tissue engineering [46,47]. 
Recently,  β-chitin/nanosilver  composite  scaffolds  were  prepared  for  wound  tissue  engineering 
applications using β-chitin hydrogel with silver nanoparticles [24]. The antibacterial, blood clotting, 
swelling, cell attachment and cytotoxicity studies of the prepared composite scaffolds were evaluated. 
The prepared β-chitin/nanosilver composite scaffolds were bactericidal against E. coli and S. aureus 
and showed good blood clotting ability as well. Cell attachment studies using Vero (epithelial cells) 
showed that the cells were well attached on the scaffolds. Similarly, α-chitin/nanosilver composite 
scaffolds  showing  similar  results  were  developed  for  wound  tissue  engineering  applications  using  
α-chitin  hydrogel  with  silver  nanoparticles  [25].  These  results  suggested  that  chitin/nanosilver 
composite scaffolds could be potential candidates for wound tissue engineering [24,25].  
3. Conclusions  
There has been a remarkable progression during the past two decades in the development of tissue 
engineering  scaffolds  which  can  be  attributed  in  large  measure  to  novel  advanced  materials.  For 
regeneration  of  complex  human  organs,  highly  porous  and  fortified  3D  molds  are  indispensable. Int. J. Mol. Sci. 2011, 12                       
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Recently,  hydrogel  scaffold  such  as  chitin  is  greatly  used  for  improving  the  functionality  of  
tissue-engineered constructs. Chitin has excellent properties such as biodegradability, bio-compatibility, 
non-toxicity and have been shown to increase wound healing in animals and humans. Chitin has also 
demonstrated a physiological compatibility with living tissues. In addition, basic and applied research 
has made great progress and it is evident that chitin exhibits an unlimited application potential for use 
in  bone, cartilage  and  wound care.  Probably, the only limitation  of chitin is  the poor  mechanical 
strength and elasticity to serve as scaffold for tissues like bone and cartilage. However, the mechanical 
property can be improved with the addition of biomaterials like hydroxyapatite (HA), bioactive glass 
ceramic (BGC), etc. and thus can be explicitly designed and tuned to match native tissues.  
The examples described in this review represent only a few of the numerous ways in which chitin 
can be used to design scaffolds for bone and cartilage tissue engineering. Similar concepts could be 
thought of for regenerating other tissues or organs using chitin scaffolds. Also, the uniqueness of the 
chitin both as 3D scaffolds and as an injectable hydrogel functionalized with desired biomolecules can 
be  widely  explored  for  various  tissue  engineering  applications.  Further  studies  are  needed  to 
demonstrate the potential uses of chitin scaffold in the tissue engineering/regenerative medicine area. 
In the area of tissue engineering and regenerative medicine, there continues to be a huge pressure to 
develop advanced materials that can better mimic the exquisite architecture and functional properties 
of native tissues. In the near future, it is most likely that the hydrogel based systems would help to 
reconcile the clinical and commercial demands in tissue engineering.  
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